VOLITIONRX LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
VolitionRx Schedules First Quarter 2015 Earnings Conference Call and Business Update for Tuesday, May 12, 2015 at 8:30 a.m. ET 2015-05-06 20:00
VolitionRx Adds Three New Laboratory Automation Systems to Expedite Sample Analysis for its Large Ongoing Clinical Trials 2015-04-09 20:00
VolitionRx Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology 2015-03-05 21:00
VolitionRx Acquires Direct Ownership of Nucleosomics(R) Technology Patent 2015-02-24 21:00
VolitionRx Limited Announces Exercise of Over-Allotment Option in Previously Announced Public Offering 2015-02-17 21:00
VolitionRx Limited Announces Closing of Public Offering of Common Stock 2015-02-12 21:00
VolitionRx Limited Prices Public Offering of Common Stock 2015-02-06 21:00
VolitionRx Begins First Ovarian Cancer Detection Study 2015-01-21 06:00
Initial Study Demonstrates that VolitionRx NuQ(R) Blood Test Has 84% Accuracy in Detecting Early Stage Treatable Pancreatic Cancers 2015-01-07 21:00
VolitionRx to Initiate Study with University Hospital Bonn to Confirm NuQ(R) Test Accuracy in Lung Cancer 2014-12-17 21:00
VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2014-11-24 21:00
VolitionRx Enters Agreement with University of Oxford to Initiate Endometriosis Study 2014-11-11 21:00
VolitionRx to Present at the SeeThruEquity Conference 2014-11-05 21:00
VolitionRx Initiates Sponsorship of Two-time Cancer Survivor to Drive Awareness for the Importance of Early Cancer Detection 2014-10-31 20:00
VolitionRx Presents Further Colorectal Cancer Data at 9th International Conference of Anticancer Research 2014-10-09 20:00
VolitionRx Sells First NuQ(R) Research Use Only Kits to Active Motif 2014-06-23 18:30
1 7 8 9 10 11